ℹ️
🇬🇧
Search
Search for publications relevant for "DNA adduct"
DNA adduct
Publication
Class
Person
Publication
Programmes
publication
Monitoring of dimethyl sulphate-induced N3-methyladenine, N7-methylguanine and O-6-methylguanine DNA adducts using reversed-phase high performance liquid chromatography and mass spectrometry
2008 |
Faculty of Science
publication
DNA adducts in genotoxicology
2006 |
Faculty of Science
publication
Covalent DNA Adduct Formation Mediated by Cytochromes 450
2004 |
Faculty of Science
publication
32P-Postlabeling Analysis of DNA Adducts
2013 |
Faculty of Science
publication
Monitoring of DNA adducts in humans and P-32-postlabelling methods. A review
2004 |
Faculty of Science
publication
Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabeling analysis of DNA adduct formation
2001 |
Faculty of Science
publication
DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique
2002 |
Faculty of Science
publication
The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells
2009 |
Second Faculty of Medicine
publication
DNA adducts, strand breaks and micronuclei in mice exposed to styrene by inhalation
2001 |
Third Faculty of Medicine
publication
Formation of DNA Adducts by Ellipticine and Its Micellar Form in Rats - A Comparative Study
2014 |
Faculty of Science
publication
The effect of pH on peroxidase-mediated oxidation of and DNA adduct formation by ellipticine
2006 |
Faculty of Science
publication
Human and rat cytochromes P450 activate anticancer drug ellipticine to metabolites forming identical DNA-adducts
2002 |
Faculty of Science
publication
The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats
2015 |
Faculty of Science
publication
CYP1A1/2 and prostaglandin H synthase catalyze reductive activation of inflammatory drug aristolochic acid and that results in DNA adduct formation
2000 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
Anticancer drug ellipticine forms DNA adducts in vivo; A novel mode of its antineoplatic action
2004 |
Faculty of Science
publication
Comparison of the cytotoxicity of and DNA adduct formation by the anticancer drug ellipticine in human breast adenocarcinoma, leukemia and neuroblastoma cells
2007 |
Faculty of Science
publication
Ellipticine forms covalent DNA adducts in rats with properties similar to adducts formed in vitro after its activation by cytochromes P450 or peroxidases
2001 |
Faculty of Science
publication
Cytotoxicity of and DNA adduct formation by ellipticine and its micellar form in human leukemia cells in vitro
2015 |
Faculty of Science, Second Faculty of Medicine
publication
Biomarkers of exposure to tobacco smoke and environmental pollutants in mothers and their transplacental transfer to the foetus. Part I: Bulky DNA adducts
2009 |
Second Faculty of Medicine
publication
Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by P-32-postlabeling
2018 |
Faculty of Science
publication
Formation and persistence of DNA adducts of anticancer drug ellipticine in rats
2007 |
Faculty of Science
publication
Peroxidase-mediated ellipticine-DNA adduct formation explains the selective efficiency of this anticancer drug against breast cancer and leukemia
2003 |
Faculty of Science
publication
DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer
2017 |
Faculty of Science
publication
Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone
2017 |
Faculty of Science
publication
Genetic polymorphisms in biotransformation enzymes for benzo[a]pyrene and related levels of benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts in Goeckerman therapy
2016 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
publication
Evaluation pf 32P-postlabelling as a suitable detection technique for biomonitoring of human DNA adducts
2003 |
Faculty of Science
publication
DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells
2007 |
Faculty of Science, Second Faculty of Medicine
publication
Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b5
2012 |
Faculty of Science
publication
Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo
2016 |
Faculty of Science
publication
Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells
2009 |
Faculty of Science, First Faculty of Medicine, Faculty of Mathematics and Physics